Corvus Pharmaceuticals, Inc.CRVS
Close of Friday, October 23, 2026 · Corvus Pharmaceuticals, Inc. is trading below its Pivot, OnlyAlpha's long-term trend line.
Price
$10.53
vs its Pivot
-26.6%
OnlyAlpha Score
48
Trend
Below its Pivot
Last 12 months. Solid line: price. Dashed green: the Pivot.
Returns
| 1 month | Year to date | 1 year | 3 years / yr | 5 years / yr |
|---|---|---|---|---|
| -10.8% | +36.8% | +46.7% | — | — |
No dividend in the last 12 months.
Who runs and owns it
In these funds
IBB · 0.05%IWM · 0.02%
Big investors that own it (latest 13F)
| OrbiMed | 2.0% of holdings |
| Perceptive Advisors | 0.6% of holdings |
| RA Capital | 0.1% of holdings |
Get CRVS in your free daily emailAfter every close: whether CRVS is above or below its Pivot, its OnlyAlpha Score, and any new buy or sell signal, along with the rest of your list.
Track CRVS free → Full Stock check
Track CRVS free → Full Stock check